Immunologix, Inc.
Advancing antibody therapeutics for combating diseases and targeting various biological threats.
Advancing antibody therapeutics for combating diseases and targeting various biological threats.
Immunologix, Inc. is a biotechnology startup with the slogan "Advancing antibody therapeutics for combating diseases and targeting various biological threats."
Founded in 2008, the company is based in Charleston, South Carolina. It focuses on creating and manufacturing antibody-based treatments for a variety of biological targets, including human monoclonal antibodies targeting viral, bacterial, and tumor antigens, as well as human auto antigens.
The company recently received a $250.95K Seed Round investment on 20 July 2011. This funding will likely contribute to further advancements in their research and development efforts. Immunologix, Inc. is positioned at the forefront of the biotechnology and pharmaceutical industries, with potential for significant growth and impact in the field of antibody therapeutics.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $250.95K | - | 20 Jul 2011 | |
| Venture Round | $890.17K | - | 13 Aug 2010 | |
| Pre Seed Round | $200.00K | 1 |
|
12 Mar 2010 |
No recent news or press coverage available for Immunologix, Inc..
We care about your data, and we'd love to use cookies make your experience better.
